Gary Rojewski - EnzymeBioSystems CEO and Director
CEO
Mr. Gary Rojewski is a Chief Executive Officer, Director of the Company. He has 29years experience in the pharmaceutical industry. During that time he has worked for Procter Gamble Pharmaceuticals, Warner Chilcott Pharmaceuticals and most recently Actavis. Throughout his pharmaceutical career he was responsible for commercializing pharmaceutical products.
| Age | 62 |
| Phone | 702-907-0615 |
| Web | http://www.enzymebiosystems.org |
EnzymeBioSystems Management Efficiency
The company has return on total asset (ROA) of (144.51) % which means that it has lost $144.51 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (278.28) %, meaning that it created substantial loss on money invested by shareholders. EnzymeBioSystems' management efficiency ratios could be used to measure how well EnzymeBioSystems manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 11 records | CEO Age | ||
| James Rourke | The Mosaic | 54 | |
| Terrence Hahn | Axalta Coating Systems | 51 | |
| Stephen Kelley | Amkor Technology | 55 | |
| Yuk Wong | Yips Chemical Holdings | 54 | |
| James ORourke | The Mosaic | 60 | |
| Chrishan Villavarayan | Axalta Coating Systems | 54 | |
| Yoshifumi Nakaya | Amkor Technology | 51 | |
| Bernie Wolford | Diamond Offshore Drilling | 64 | |
| Marc Edwards | Diamond Offshore Drilling | 58 | |
| Kam Wong | Yips Chemical Holdings | 53 | |
| Robert Bryant | Axalta Coating Systems | 51 | |
Management Performance
| Return On Equity | -278.28 | |||
| Return On Asset | -144.51 |
EnzymeBioSystems Leadership Team
Elected by the shareholders, the EnzymeBioSystems' board of directors comprises two types of representatives: EnzymeBioSystems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EnzymeBioSystems. The board's role is to monitor EnzymeBioSystems' management team and ensure that shareholders' interests are well served. EnzymeBioSystems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EnzymeBioSystems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Zimmerman, CFO | ||
| John Harper, Interim Accounting Officer, Corporate Secretary | ||
| Gary Rojewski, CEO and Director | ||
| Ashot Martirosyan, Chief Scientific Officer and Director |
EnzymeBioSystems Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is EnzymeBioSystems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -278.28 | |||
| Return On Asset | -144.51 | |||
| Current Valuation | (390.86 K) | |||
| Shares Outstanding | 5.59 M | |||
| Shares Owned By Insiders | 46.13 % | |||
| Price To Earning | (13.02) X | |||
| Net Income | (626.77 K) | |||
| Cash And Equivalents | 391.42 K | |||
| Cash Per Share | 0.07 X | |||
| Current Ratio | 150.55 X |
Pair Trading with EnzymeBioSystems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnzymeBioSystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnzymeBioSystems will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Southwestern Energy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Southwestern Energy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Southwestern Energy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Southwestern Energy to buy it.
The correlation of Southwestern Energy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Southwestern Energy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Southwestern Energy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Southwestern Energy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the EnzymeBioSystems information on this page should be used as a complementary analysis to other EnzymeBioSystems' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in EnzymeBioSystems Pink Sheet
If you are still planning to invest in EnzymeBioSystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EnzymeBioSystems' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |